Thygeson's superficial punctate keratitis: ten years' experience

Area of Science:

• Ophthalmology
• Corneal Diseases
• Ocular Surface Disorders

Background:

• Thygeson's superficial punctate keratitis (TSPK) is an inflammatory eye condition.
• Understanding its presentation, treatment, and long-term course is crucial for patient management.

Purpose of the Study:

• To evaluate the clinical presentation, treatment strategies, and disease progression of Thygeson's superficial punctate keratitis.
• To analyze patient demographics and outcomes over a defined period.

Main Methods:

• Retrospective observational case series.
• Review of charts from 40 patients diagnosed with TSPK between 1992 and 2001.
• Data collected included demographics, symptoms, visual acuity, examination findings, management, and follow-up duration.

Main Results:

• The mean age of patients was 28.7 years, with photophobia, blurred vision, and irritation as common symptoms.
• Most patients (78.9%) presented with good visual acuity (20/30 or better), with improvement noted after treatment.
• Topical steroids were the primary treatment (97.5%), with extended-wear contact lenses and topical cyclosporine used as secondary options for recalcitrant cases.

Conclusions:

• Thygeson's superficial punctate keratitis can be a chronic condition, potentially lasting for years to decades.
• Corticosteroids are the primary treatment; contact lenses and cyclosporine are reserved for specific cases.
• Ophthalmologists should be aware of the chronic nature and varied presentation of TSPK.